Filing Details

Accession Number:
0000899243-22-012152
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-24 21:00:25
Reporting Period:
2022-03-22
Accepted Time:
2022-03-24 21:00:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1808865 Iteos Therapeutics Inc. ITOS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1465914 I. Aaron Davis 12860 El Camino Real, Suite 300
San Diego CA 92130
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-03-22 21,300 $31.88 3,163,358 No 4 P Indirect See footnote
Common Stock Acquisiton 2022-03-22 3,700 $33.09 3,167,058 No 4 P Indirect See footnote
Common Stock Acquisiton 2022-03-22 5,000 $33.43 3,172,058 No 4 P Indirect See footnote
Common Stock Acquisiton 2022-03-23 20,000 $32.85 3,192,058 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
No 4 P Indirect See footnote
No 4 P Indirect See footnote
No 4 P Indirect See footnote
Footnotes
  1. These securities are owned directly by Boxer Capital, LLC ("Boxer Capital"). The reporting person may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) the reporting person, and (iv) Joe Lewis. The reporting person disclaims beneficial ownership of these securities to the extent he does not have a pecuniary interest therein.